Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 638

1.

AB569, a nontoxic chemical tandem that kills major human pathogenic bacteria.

McDaniel CT, Panmanee W, Winsor GL, Gill E, Bertelli C, Schurr MJ, Dongare P, Paul AT, Ko SB, Lau GW, Dasgupta N, Bogue AL, Miller WE, Mortensen JE, Haslam DB, Dexheimer P, Muruve DA, Aronow BJ, Forbes MDE, Danilczuk M, Brinkman FSL, Hancock REW, Meyer TJ, Hassett DJ.

Proc Natl Acad Sci U S A. 2020 Feb 18. pii: 201911927. doi: 10.1073/pnas.1911927117. [Epub ahead of print]

PMID:
32071223
2.

Multidrug adaptive resistance of Pseudomonas aeruginosa swarming cells.

Coleman SR, Blimkie T, Falsafi R, Hancock REW.

Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.01999-19. doi: 10.1128/AAC.01999-19. [Epub ahead of print]

PMID:
31844008
3.

Influence of Non-natural Cationic Amino Acids on the Biological Activity Profile of Innate Defense Regulator Peptides.

Haney EF, Barbosa SC, Baquir B, Hancock REW.

J Med Chem. 2019 Nov 27;62(22):10294-10304. doi: 10.1021/acs.jmedchem.9b01344. Epub 2019 Nov 12.

PMID:
31664827
4.

Metabolomics Study of the Synergistic Killing of Polymyxin B in Combination with Amikacin against Polymyxin-Susceptible and -Resistant Pseudomonas aeruginosa.

Hussein M, Han ML, Zhu Y, Zhou Q, Lin YW, Hancock REW, Hoyer D, Creek DJ, Li J, Velkov T.

Antimicrob Agents Chemother. 2019 Dec 20;64(1). pii: e01587-19. doi: 10.1128/AAC.01587-19. Print 2019 Dec 20.

PMID:
31611351
5.

Effect of Long-term Exposure to Peptides on Mono- and Multispecies Biofilms in Dentinal Tubules.

Huang X, Haapasalo M, Wang Z, Hancock REW, Wei X, Shen Y.

J Endod. 2019 Dec;45(12):1522-1528. doi: 10.1016/j.joen.2019.09.003. Epub 2019 Oct 9.

PMID:
31606145
6.

A Genome-Wide Knockout Screen in Human Macrophages Identified Host Factors Modulating Salmonella Infection.

Yeung ATY, Choi YH, Lee AHY, Hale C, Ponstingl H, Pickard D, Goulding D, Thomas M, Gill E, Kim JK, Bradley A, Hancock REW, Dougan G.

mBio. 2019 Oct 8;10(5). pii: e02169-19. doi: 10.1128/mBio.02169-19.

7.

Outer Membrane Interaction Kinetics of New Polymyxin B Analogs in Gram-Negative Bacilli.

Akhoundsadegh N, Belanger CR, Hancock REW.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00935-19. doi: 10.1128/AAC.00935-19. Print 2019 Oct.

PMID:
31332075
8.

Hyaluronic acid-based nanogels improve in vivo compatibility of the anti-biofilm peptide DJK-5.

Kłodzińska SN, Pletzer D, Rahanjam N, Rades T, Hancock REW, Nielsen HM.

Nanomedicine. 2019 Aug;20:102022. doi: 10.1016/j.nano.2019.102022. Epub 2019 Jun 4.

PMID:
31170510
9.

Short Cationic Peptide Derived from Archaea with Dual Antibacterial Properties and Anti-Infective Potential.

Cândido ES, Cardoso MH, Chan LY, Torres MDT, Oshiro KGN, Porto WF, Ribeiro SM, Haney EF, Hancock REW, Lu TK, de la Fuente-Nunez C, Craik DJ, Franco OL.

ACS Infect Dis. 2019 Jul 12;5(7):1081-1086. doi: 10.1021/acsinfecdis.9b00073. Epub 2019 May 1.

PMID:
31016969
10.

Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.

Gibson KM, Morishita KA, Dancey P, Moorehead P, Drögemöller B, Han X, Graham J, Hancock REW, Foell D, Benseler S, Luqmani R, Yeung RSM, Shenoi S, Bohm M, Rosenberg AM, Ross CJ, Cabral DA, Brown KL; PedVas Investigators Network.

Arthritis Rheumatol. 2019 Oct;71(10):1747-1755. doi: 10.1002/art.40913. Epub 2019 Aug 26.

PMID:
31008556
11.

NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis.

Zhou G, Soufan O, Ewald J, Hancock REW, Basu N, Xia J.

Nucleic Acids Res. 2019 Jul 2;47(W1):W234-W241. doi: 10.1093/nar/gkz240.

12.

Dismantling the bacterial virulence program.

Alford MA, Pletzer D, Hancock REW.

Microb Biotechnol. 2019 May;12(3):409-413. doi: 10.1111/1751-7915.13388. Epub 2019 Mar 12.

13.

Dynamic molecular changes during the first week of human life follow a robust developmental trajectory.

Lee AH, Shannon CP, Amenyogbe N, Bennike TB, Diray-Arce J, Idoko OT, Gill EE, Ben-Othman R, Pomat WS, van Haren SD, Cao KL, Cox M, Darboe A, Falsafi R, Ferrari D, Harbeson DJ, He D, Bing C, Hinshaw SJ, Ndure J, Njie-Jobe J, Pettengill MA, Richmond PC, Ford R, Saleu G, Masiria G, Matlam JP, Kirarock W, Roberts E, Malek M, Sanchez-Schmitz G, Singh A, Angelidou A, Smolen KK; EPIC Consortium, Brinkman RR, Ozonoff A, Hancock REW, van den Biggelaar AHJ, Steen H, Tebbutt SJ, Kampmann B, Levy O, Kollmann TR.

Nat Commun. 2019 Mar 12;10(1):1092. doi: 10.1038/s41467-019-08794-x.

14.

Reassessing the Host Defense Peptide Landscape.

Haney EF, Straus SK, Hancock REW.

Front Chem. 2019 Feb 4;7:43. doi: 10.3389/fchem.2019.00043. eCollection 2019. Review.

15.

A lipidic delivery system of a triple vaccine adjuvant enhances mucosal immunity following nasal administration in mice.

Wasan EK, Syeda J, Strom S, Cawthray J, Hancock RE, Wasan KM, Gerdts V.

Vaccine. 2019 Mar 7;37(11):1503-1515. doi: 10.1016/j.vaccine.2019.01.058. Epub 2019 Feb 7.

PMID:
30739796
16.

Aurein-Derived Antimicrobial Peptides Formulated with Pegylated Phospholipid Micelles to Target Methicillin-Resistant Staphylococcus aureus Skin Infections.

Kumar P, Pletzer D, Haney EF, Rahanjam N, Cheng JTJ, Yue M, Aljehani W, Hancock REW, Kizhakkedathu JN, Straus SK.

ACS Infect Dis. 2019 Mar 8;5(3):443-453. doi: 10.1021/acsinfecdis.8b00319. Epub 2019 Jan 2.

PMID:
30565465
17.

Bone Environment Influences Irreversible Adhesion of a Methicillin-Susceptible Staphylococcus aureus Strain.

Reffuveille F, Josse J, Velard F, Lamret F, Varin-Simon J, Dubus M, Haney EF, Hancock REW, Mongaret C, Gangloff SC.

Front Microbiol. 2018 Nov 27;9:2865. doi: 10.3389/fmicb.2018.02865. eCollection 2018.

18.

S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies.

Brown KL, Lubieniecka JM, Armaroli G, Kessel K, Gibson KM, Graham J, Liu D, Hancock REW, Ross CJ, Benseler SM, Luqmani RA, Cabral DA, Foell D, Kessel C.

Front Pediatr. 2018 Nov 23;6:341. doi: 10.3389/fped.2018.00341. eCollection 2018.

19.

Is synergy the key to treating high-density infections?

Pletzer D, Hancock RE.

Future Microbiol. 2018 Nov;13:1629-1632. doi: 10.2217/fmb-2018-0216. Epub 2018 Nov 14. No abstract available.

PMID:
30426796
20.

Characterization of Host Responses during Pseudomonas aeruginosa Acute Infection in the Lungs and Blood and after Treatment with the Synthetic Immunomodulatory Peptide IDR-1002.

Wuerth K, Lee AHY, Falsafi R, Gill EE, Hancock REW.

Infect Immun. 2018 Dec 19;87(1). pii: e00661-18. doi: 10.1128/IAI.00661-18. Print 2019 Jan.

Supplemental Content

Loading ...
Support Center